Irvine Medical Products Company B. Braun Recalls Possibly Tainted Heparin

Nov. 3, 2010
Sign up for our eNewsletters
Get the latest news and updates

Related

Lonza divests capsules and health ingredients business for $2.2B in upfront cash
Siegfried says customer uncertainty weighs on drug substances sales growth in 2026
2026 Manufacturing Pharma Trends for Life Sciences
Sponsored
2026 AI Trends in Life Sciences
Sponsored